Key result
Transapical off-pump NeoChord implantation achieves early procedural success without complications in 2 severe MR patients.
Why the study?
Does transapical off-pump artificial chordae implantation using the NeoChord system provide a feasible and safe treatment in patients with severe mitral regurgitation due to posterior leaflet prolapse?
Case Report (n=2)
Does transapical off-pump artificial chordae implantation using the NeoChord system provide a feasible and safe treatment in patients with severe mitral regurgitation due to posterior leaflet prolapse?
Transapical off-pump artificial chordae implantation using the NeoChord system is a feasible and safe technique for treating severe mitral regurgitation due to posterior leaflet prolapse.
No takes yet. Share an insight, caveat, or question.
May enable off-pump mitral repair in selected patients; leaves open durability, safety, and comparative efficacy.
Wróbel et al. (2016) conducted a case report in Severe mitral regurgitation due to posterior leaflet prolapse (n=2). Transapical off-pump artificial chordae implantation (NeoChord DS1000 system) was evaluated on Early procedural success. Transapical off-pump artificial chordae implantation using the NeoChord DS1000 system achieved early procedural success in 2 patients with severe mitral regurgitation, with no complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: